Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Why Sensata Technologies (ST) Stock Is Down Today

March 27, 2025 at 14:49 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

ST Cover Image

What Happened?

Shares of sensor manufacturer Sensata Technology (NYSE: ST) fell 7.2% in the afternoon session after semiconductor stocks with significant exposure to the auto sector fell after US President Donald Trump announced a 25% tariff on all vehicles imported into the United States. The move raised concerns about a potential slowdown in global auto production, which would likely dampen demand for semiconductors used in automotive manufacturing.

Adding to investor anxiety, markets also appeared concerned that similar tariffs could eventually be extended to chipmakers.

Overall, the tariff announcement was poorly received by the broader market. The major indices pulled back slightly, reflecting growing worries about the potential negative impact on corporate earnings and economic growth.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Sensata Technologies? Access our full analysis report here, it’s free.

What The Market Is Telling Us

Sensata Technologies’s shares are not very volatile and have only had 9 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.

The biggest move we wrote about over the last year was 11 months ago, when the stock gained 20.4% on the news that the company reported first quarter results, which exceeded analysts' EPS expectations. Its revenue also outperformed Wall Street's estimates. That guidance for next quarter was in line with expectations, showing that this company was on track.

The company also announced the retirement of CEO and President Jeff Cote; Martha Sullivan was appointed Interim President and CEO. Also, in consultation with activist investors, Elliott Investment Management, Sensata appointed Phillip Eyler to the Company's Board. Zooming out, we think this was still a decent, albeit mixed, quarter.

Sensata Technologies is down 4.8% since the beginning of the year, and at $25.93 per share, it is trading 39.7% below its 52-week high of $43.02 from May 2024. Investors who bought $1,000 worth of Sensata Technologies’s shares 5 years ago would now be looking at an investment worth $891.07.

Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article